{"pageContent": "Introduction: Prostate cancer is the most frequent cancer among males in Europe and a leading cause of cancer deaths, with similar proportion in other developed countries. For more than twenty years, external-beam radiation therapy, alongside with radical prostatectomy, has been used as a primary radical therapeutic approach for localized prostate cancer. Yet, EBRT failures relate to 22-69% following curative radiotherapy (\u00b1 androgen deprivation therapy). Additionally, a proportion of these men will have a biopsy-proven local recurrence.", "metaData": {"source": "[MRI and prostate cancer: a paradigm shift]\nhttps://pubmed.ncbi.nlm.nih.gov/18772783/"}}